Arab S, Rutka J, Lingwood C
Section of Infection, Immunity, Injury & Repair and Brain Tumor Research Laboratory, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.
Oncol Res. 1999;11(1):33-9.
Verotoxin 1 (VT1) is an E. coli elaborated subunit toxin active only against (tumor) cell lines that express the VT1 receptor, globotriaosyl ceramide-Gb3. Astrocytomas can be highly malignant brain tumors that remain refractory to clinical treatment. Some human astrocytoma cell lines are particularly sensitive to VT1 in vitro. To address whether this represents a feasible approach to the elimination of these tumors in man, human astrocytoma tumor xenografts in nude mice were treated with verotoxin. Following a single low-dose intratumoral injection of VT1, complete regression of a 1-cm-diameter tumor within 10 days was observed in all treated animals, without reoccurrence (up to 60 days). Apoptosis was demonstrated in both tumor and vascular cells within the treated xenograft. Verotoxin binding to tumor cells and blood vessels in sections of primary glioblastoma multiforme was found.
志贺毒素1(VT1)是一种由大肠杆菌产生的亚基毒素,仅对表达VT1受体(球三糖基神经酰胺-Gb3)的(肿瘤)细胞系有活性。星形细胞瘤是高度恶性的脑肿瘤,临床治疗仍难以治愈。一些人类星形细胞瘤细胞系在体外对VT1特别敏感。为了探讨这是否是一种在人体中消除这些肿瘤的可行方法,用志贺毒素处理了裸鼠体内的人类星形细胞瘤肿瘤异种移植模型。在单次低剂量瘤内注射VT1后,所有接受治疗的动物在10天内直径1厘米的肿瘤完全消退,且无复发(长达60天)。在处理后的异种移植瘤内的肿瘤细胞和血管细胞中均显示出凋亡。在多形性胶质母细胞瘤原发灶切片中发现志贺毒素与肿瘤细胞和血管结合。